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Here, we present a fast and convenient strategy for developing a high-cell density perfusion process for 
antibody-producing Chinese hamster ovary (CHO) cells based on the commercially available ActiCHO™ 
Media System. ActiCHO P base medium was used as a starting point and ActiCHO Feed-A and Feed-
B were added in various concentrations as supplements. The resulting perfusion medium prototypes 
were first evaluated in batch cultures, applying a design of experiment (DoE) strategy (Figure 1), and 
then tested in small-scale perfusion cultures in rocking single-use WAVE bioreactor™ systems (Figure 
2). The medium optimization resulted in a final process with a cell-specific perfusion rate (CSPR) of less 
than 50 pL/cell/d, which is a more than 45% decrease compared with the starting process conditions. 
The performance of the perfusion process was further validated in lab-scale single-use stirred-tank 
bioreactor systems. Productivity and product quality of the perfusion process were compared with a 
standard fed-batch culture process. 
 
 




Figure 2. Confirmation under steady-state conditions at 50 MVC/mL and 1 RV/d ( = CSPR 20). 
 
